Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey, shows that rapid weight loss (RWL) ...

Real world data showed clinically meaningful BMI reductions with setmelanotide in 62 adults with 12-month data living with acquired ...

New treatment option: FDA approved Zepbound in 2024 as the first drug specifically for obstructive sleep apnea in adults with obesity. Study-backed benefits: A JAMA study found GLP-1 users were less ...

MBX Biosciences (NASDAQ:MBX) used its Obesity Day event to outline preliminary clinical data for its lead obesity candidate ...

It remains positive about its outlook for 2026, despite a stock price plunge and increased competition. Read more at straitstimes.com. Read more at straitstimes.com.

These are trying times for the health care technology industry, but a turnaround may be on the way for investors who have patience. The benchmark Global X HealthTech ETF (ticker: ...

Allied Market Research published a report titled," Weight Management Market Size was valued at USD 144.6 billion in 2023 and ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 1:00 PM EDTCompany ParticipantsJames Bradner - Executive Vice President ...

The global weight loss industry was valued at $16.3 billion in 2025, yet peer-reviewed clinical validation of program outcomes remains uneven across the category; Randomized contr ...

The US President is desperate for a win. China is thinking about the next century ...

Pfizer’s first quarter results reflected continued momentum in its core portfolio, with management attributing growth to ...